Atlas Trials

Rasburicase (Fasturtec) Registration Trial

Clinical trial NCT00607152 · TERMINATED

Trial details

NCT number
NCT00607152
Sponsor
Sanofi
Status
TERMINATED
Phase
Phase 3
Study type
INTERVENTIONAL
Hyperuricemia
Start date
2007-10-01
Primary completion
2009-01-01
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.